Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hyperliquid Strategies Inc (PURR : NSDQ)

• Company Description    Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK. Number of Employees: 5

• Price / Volume Information    Yesterday's Closing Price: $11.01 Daily Weekly Monthly 20 Day Moving Average: 26,910,996 shares Shares Outstanding: 197.84 (millions) Market Capitalization: $2,178.19 (millions) Beta: 1.89 52 Week High: $14.14 52 Week Low: $3.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 61.44% 65.85% 12 Week 18.64% 17.22% Year To Date 209.27% 178.87%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 477 MADISON AVENUE 22ND FLOOR - NEW YORK,NY 10022 USA ph: 212-883-4241 fax: 704-366-2463 investors@hypestrat.xyz http://www.hypestrat.xyz

• General Corporate Information    Officers David Schamis - Chief Executive Officer Brett Beldner - Chief Financial Officer Bob Diamond - Director Jeff Tuder - Director Eric S. Rosengren - Director Peer Information Hyperliquid Strategies Inc (EIIN) Hyperliquid Strategies Inc (AFMI) Hyperliquid Strategies Inc (DRL) Hyperliquid Strategies Inc (GRFPY) Hyperliquid Strategies Inc (IGOT) Hyperliquid Strategies Inc (ATLC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-MISC SVCS Sector: Finance CUSIP: 44916Y106 SIC: 6199 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/27/26 Share - Related Items Shares Outstanding: 197.84 Most Recent Split Date: 9.00 (0.13:1) Beta: 1.89 Market Capitalization: $2,178.19 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.21 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/27/26

• Fundamental Ratios P/E Current FY Estimate: 3.43 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.18 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 213.48% vs. Previous Quarter: 113.59% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 103.12% ROE 06/30/26 - 35.55 03/31/26 - -56.99 12/31/25 - -213.44 ROA 06/30/26 - 32.65 03/31/26 - -53.10 12/31/25 - -201.77 Current Ratio 06/30/26 - 41.62 03/31/26 - 18.23 12/31/25 - 31.62 Quick Ratio 06/30/26 - 41.62 03/31/26 - 18.22 12/31/25 - 31.62 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - 5,169.31 03/31/26 - -2,778.57 12/31/25 - -57,105.80 Book Value 06/30/26 - 9.34 03/31/26 - 5.99 12/31/25 - 4.64 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©